as 11-15-2024 4:00pm EST
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
Founded: | 2007 | Country: | United States |
Employees: | N/A | City: | GOLDEN VALLEY |
Market Cap: | 5.2B | IPO Year: | 2018 |
Target Price: | $226.18 | AVG Volume (30 days): | 570.0K |
Analyst Decision: | Buy | Number of Analysts: | 11 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 1.09 | EPS Growth: | N/A |
52 Week Low/High: | $123.00 - $257.40 | Next Earning Date: | 11-04-2024 |
Revenue: | $755,594,000 | Revenue Growth: | 32.52% |
Revenue Growth (this year): | 29.96% | Revenue Growth (next year): | 19.42% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Rondoni John | INSP | Chief Technology Officer | Sep 9 '24 | Sell | $215.00 | 31 | $6,665.00 | 11,348 | |
McCormick Shawn | INSP | Director | Sep 9 '24 | Sell | $220.00 | 800 | $176,000.00 | 23,140 | |
Rondoni John | INSP | Chief Technology Officer | Aug 22 '24 | Sell | $189.60 | 5,000 | $949,143.12 | 11,348 |
INSP Breaking Stock News: Dive into INSP Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Argus Research
5 days ago
GlobeNewswire
6 days ago
Simply Wall St.
10 days ago
GlobeNewswire
11 days ago
TipRanks
11 days ago
Simply Wall St.
11 days ago
Argus Research
12 days ago
The information presented on this page, "INSP Inspire Medical Systems Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.